228 related articles for article (PubMed ID: 25796145)
1. Research on green supply chain coordination strategy for uncertain market demand.
Cao J; Chen Y; Lu B; Tong C; Zhou G
Pak J Pharm Sci; 2015 Mar; 28(2 Suppl):687-92. PubMed ID: 25796145
[TBL] [Abstract][Full Text] [Related]
2. Pharmaceutical supply chain in China: current issues and implications for health system reform.
Yu X; Li C; Shi Y; Yu M
Health Policy; 2010 Sep; 97(1):8-15. PubMed ID: 20307912
[TBL] [Abstract][Full Text] [Related]
3. Supply chain decision based on green investment subsidy and risk aversion.
Liu P; Yu S; Lin Z
PLoS One; 2023; 18(11):e0293924. PubMed ID: 37931002
[TBL] [Abstract][Full Text] [Related]
4. Looking inward: regional parallel trade as a means of bringing affordable drugs to Africa.
Buckely M
Seton Hall Law Rev; 2011; 41(2):625-69. PubMed ID: 21739760
[No Abstract] [Full Text] [Related]
5. Maintaining drug supply to Greece in an uncertain future.
Burki TK
Lancet Oncol; 2015 Aug; 16(8):e382. PubMed ID: 26166437
[No Abstract] [Full Text] [Related]
6. Supporting the production of pharmaceuticals in Africa.
Dong J; Mirza Z
Bull World Health Organ; 2016 Jan; 94(1):71-2. PubMed ID: 26769999
[No Abstract] [Full Text] [Related]
7. The Health Impact Fund: incentives for improving access to medicines.
Banerjee A; Hollis A; Pogge T
Lancet; 2010 Jan; 375(9709):166-9. PubMed ID: 20109894
[No Abstract] [Full Text] [Related]
8. Impact of parallel trade on pharmaceutical firm's profits: rise or fall?
Guo S; Hu B; Zhong H
Eur J Health Econ; 2013 Apr; 14(2):345-55. PubMed ID: 22286662
[TBL] [Abstract][Full Text] [Related]
9. Creating reliable pharmaceutical distribution networks and supply chains in African countries: Implications for access to medicines.
Tetteh E
Res Social Adm Pharm; 2009 Sep; 5(3):286-97. PubMed ID: 19733829
[No Abstract] [Full Text] [Related]
10. Future supply chains enabled by continuous processing--opportunities and challenges. May 20-21, 2014 Continuous Manufacturing Symposium.
Srai JS; Badman C; Krumme M; Futran M; Johnston C
J Pharm Sci; 2015 Mar; 104(3):840-9. PubMed ID: 25631279
[TBL] [Abstract][Full Text] [Related]
11. Should the patent system for pharmaceuticals be replaced? A theoretical approach.
Antoñanzas F; Rodríguez-Ibeas R; Juárez-Castelló CA
Expert Rev Pharmacoecon Outcomes Res; 2014 Oct; 14(5):617-26. PubMed ID: 24934980
[TBL] [Abstract][Full Text] [Related]
12. TRIPS, pharmaceutical patents, and access to essential medicines: a long way from Seattle to Doha.
't Hoen E
Chic J Int Law; 2002; 3(1):27-46. PubMed ID: 15709298
[No Abstract] [Full Text] [Related]
13. Should the US allow prescription drug reimports from Canada?
Pecorino P
J Health Econ; 2002 Jul; 21(4):699-708. PubMed ID: 12146598
[TBL] [Abstract][Full Text] [Related]
14. Research on green decision making of pharmaceutical logistics considering government subsidy strategy.
Huang Z; Fu M
PLoS One; 2020; 15(10):e0241400. PubMed ID: 33125413
[TBL] [Abstract][Full Text] [Related]
15. Green Supply Chain Decisions Under Different Power Structures: Wholesale Price vs. Revenue Sharing Contract.
Liu X; Du W; Sun Y
Int J Environ Res Public Health; 2020 Oct; 17(21):. PubMed ID: 33105880
[TBL] [Abstract][Full Text] [Related]
16. Global "hold-em".
Cassidy BS
Geriatr Nurs; 2006; 27(1):21-3. PubMed ID: 16483897
[No Abstract] [Full Text] [Related]
17. [Not available, cope with it: an unacceptable scandal].
Aapro M; Dietrich PY; Leyvraz S
Rev Med Suisse; 2012 May; 8(342):1083-4. PubMed ID: 22734175
[No Abstract] [Full Text] [Related]
18. Bringing business risk into sharp focus.
Gruber B; Walsh E
Nat Biotechnol; 2012 Jan; 30(1):30-2. PubMed ID: 22231088
[No Abstract] [Full Text] [Related]
19. Marketing decision support systems for strategy building.
Rao SK
Mark Health Serv; 2000; 20(2):14-8. PubMed ID: 11183424
[TBL] [Abstract][Full Text] [Related]
20. Green supply chain game model and contract design: risk neutrality vs. risk aversion.
Cai J; Lin H; Hu X; Ping M
Environ Sci Pollut Res Int; 2022 Jul; 29(34):51871-51891. PubMed ID: 35257336
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
